Geneos Wealth Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Geneos Wealth Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-300	Closed	-$11.8K	–	2163
2023 Q2	$11.8K	Hold	300	–	–	﹤0.01%	1530
2023 Q1	$7.3K	Hold	300	–	–	﹤0.01%	1633
2022 Q4	$6.42K	Buy	+300	New	+$6.4K	﹤0.01%	1649

Geneos Wealth Management's ISEE Position: Q3 2023 in Review

Geneos Wealth Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 300 shares — an estimated $11.8K sold.

Geneos Wealth Management first reported a position in ISEE in Q4 2022 and held it in 3 quarters. The position peaked at $11.8K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Geneos Wealth Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Geneos Wealth Management sold 300 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $11.8K.
Geneos Wealth Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
Geneos Wealth Management's IVERIC bio, Inc. Common Stock position peaked at $11.8K in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Geneos Wealth Management's 13F filing for Q3 2023, filed 11 Oct 2023.